0001741198-19-000001.txt : 20190919 0001741198-19-000001.hdr.sgml : 20190919 20190919132055 ACCESSION NUMBER: 0001741198-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190919 DATE AS OF CHANGE: 20190919 EFFECTIVENESS DATE: 20190919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emergo Therapeutics, Inc. CENTRAL INDEX KEY: 0001741198 IRS NUMBER: 814088686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-312872 FILM NUMBER: 191101414 BUSINESS ADDRESS: STREET 1: 6208 FAYETTEVILLE ROAD #104 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-599-4381 MAIL ADDRESS: STREET 1: 6208 FAYETTEVILLE ROAD #104 CITY: DURHAM STATE: NC ZIP: 27713 D/A 1 primary_doc.xml X0708 D/A LIVE 0001741198 Emergo Therapeutics, Inc. 6208 FAYETTEVILLE ROAD #104 DURHAM NC NORTH CAROLINA 27713 919-599-4381 DELAWARE None None Corporation true 2016 Moise Khayrallah 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Executive Officer Director Robin Hyde-DeRuyscher 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Executive Officer John E. Bailey, Jr. 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Robert Helmedag 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Margaret Powell 6208 Fayetteville Road #104 Durham NC NORTH CAROLINA 27713 Director Pharmaceuticals Decline to Disclose 06b true 0001741198-18-000001 2018-05-22 true true false 10000 12000000 12000000 0 false 110 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Emergo Therapeutics, Inc. Moise Khayrallah Moise Khayrallah CEO 2019-09-12